Oropharyngeal Administration of Mother's Colostrum for Premature Infants (NS-72393-360)

NACompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

November 20, 2013

Primary Completion Date

October 30, 2021

Study Completion Date

January 4, 2022

Conditions
InfectionEnterocolitis, NecrotizingVentilator-associated Pneumonia
Interventions
OTHER

oropharyngeal mother's milk

Application of 0.2 mL of own mother's milk onto the infant's oral mucosa, for an initial treatment period of every 2 hours for 48 hours, followed by an extended treatment period of every 3 hours until 32 weeks corrected gestational age

OTHER

oropharyngeal sterile water

Application of 0.2 mL of sterile water onto the infant's oral mucosa, for an initial treatment period of every 2 hours for 48 hours, followed by an extended treatment period of every 3 hours until 32 weeks corrected gestational age

Trial Locations (5)

60068

Advocate Children's Hospital-Park Ridge, Park Ridge

60201

NorthShore University health System, Evanston

33143-4679

South Miami Hospital, Miami

07960

Morristown Medical Center, Morristown

28403-6024

Betty Cameron Women & Children's Hospital, Wilmington

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

The Gerber Foundation

OTHER

collaborator

Fundacion Para La Investigacion Hospital La Fe

OTHER

collaborator

University of Chicago

OTHER

lead

Endeavor Health

OTHER

NCT02116699 - Oropharyngeal Administration of Mother's Colostrum for Premature Infants (NS-72393-360) | Biotech Hunter | Biotech Hunter